Published in Lab Invest on January 01, 2004
The transcriptome of retinal Müller glial cells. J Comp Neurol (2008) 2.17
Digital transcriptome profiling from attomole-level RNA samples. Genome Res (2010) 1.83
Options available for profiling small samples: a review of sample amplification technology when combined with microarray profiling. Nucleic Acids Res (2006) 1.74
Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression. Biol Psychiatry (2010) 1.49
Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease. Neurobiol Dis (2011) 1.31
Single cell gene expression profiling in Alzheimer's disease. NeuroRx (2006) 1.22
Limitations of mRNA amplification from small-size cell samples. BMC Genomics (2005) 1.19
Highly parallel genome-wide expression analysis of single mammalian cells. PLoS One (2012) 1.10
Effective transcriptome amplification for expression profiling on sense-oriented oligonucleotide microarrays. Nucleic Acids Res (2005) 1.09
A robust method for the amplification of RNA in the sense orientation. BMC Genomics (2005) 1.07
Transcriptional profiling of small samples in the central nervous system. Methods Mol Biol (2008) 1.03
Terminal continuation (TC) RNA amplification without second strand synthesis. J Neurosci Methods (2008) 1.01
Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction. Neurobiol Dis (2011) 0.97
Terminal Continuation (TC) RNA amplification enables expression profiling using minute RNA input obtained from mouse brain. Int J Mol Sci (2008) 0.96
Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment. Neuropharmacology (2013) 0.92
Galanin fiber hyperinnervation preserves neuroprotective gene expression in cholinergic basal forebrain neurons in Alzheimer's disease. J Alzheimers Dis (2009) 0.92
Galanin hyperinnervation upregulates choline acetyltransferase expression in cholinergic basal forebrain neurons in Alzheimer's disease. Neurodegener Dis (2008) 0.89
Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. J Chem Neuroanat (2011) 0.86
Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD). Brain Struct Funct (2014) 0.86
Using luminescent nanoparticles as staining probes for Affymetrix GeneChips. Bioconjug Chem (2007) 0.85
Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease. Am J Pathol (2011) 0.85
Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease. J Chem Neuroanat (2011) 0.83
Alterations in discrete glutamate receptor subunits in adult mouse dentate gyrus granule cells following perforant path transection. Anal Bioanal Chem (2010) 0.81
Expression profile analysis of vulnerable CA1 pyramidal neurons in young-Middle-Aged Ts65Dn mice. J Comp Neurol (2014) 0.80
Hypothesis: Artifacts, Including Spurious Chimeric RNAs with a Short Homologous Sequence, Caused by Consecutive Reverse Transcriptions and Endogenous Random Primers. J Cancer (2015) 0.80
Isolation of mouse neuritic mRNAs. J Mol Histol (2006) 0.78
Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease. Neurobiol Aging (2016) 0.78
Optimized amplification and single-cell analysis identify GnRH-mediated activation of Rap1b in primary rat gonadotropes. Mol Cell Endocrinol (2011) 0.76
An alternative method to amplify RNA without loss of signal conservation for expression analysis with a proteinase DNA microarray in the ArrayTube format. BMC Genomics (2006) 0.76
It Is Imperative to Establish a Pellucid Definition of Chimeric RNA and to Clear Up a Lot of Confusion in the Relevant Research. Int J Mol Sci (2017) 0.75
Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease. Acta Neuropathol Commun (2017) 0.75
Methods and compositions for amplification and detection of microRNAs (miRNAs) and noncoding RNAs (ncRNAs) using the signature sequence amplification method (SSAM). Recent Adv DNA Gene Seq (2014) 0.75
Single-cell and regional gene expression analysis in Alzheimer's disease. Cell Mol Neurobiol (2012) 0.75
Alzheimer's-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition. Proc Natl Acad Sci U S A (2009) 1.72
Cholinergic system during the progression of Alzheimer's disease: therapeutic implications. Expert Rev Neurother (2008) 1.63
Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J Chem Neuroanat (2003) 1.50
Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway. Proc Natl Acad Sci U S A (2010) 1.45
Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease. Ann Neurol (2004) 1.43
Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology (2008) 1.32
Identification of CSPα clients reveals a role in dynamin 1 regulation. Neuron (2012) 1.28
Mild cognitive impairment: pathology and mechanisms. Acta Neuropathol (2011) 1.20
Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch Gen Psychiatry (2002) 1.20
Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease. J Neurosci (2009) 1.19
Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease. Arch Neurol (2007) 1.16
An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain. J Neurosci (2002) 1.15
Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease. Neurochem Res (2002) 1.12
Sex- and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease. Mol Brain (2010) 1.01
Terminal continuation (TC) RNA amplification without second strand synthesis. J Neurosci Methods (2008) 1.01
Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease. Prog Brain Res (2006) 1.01
Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model. J Neurochem (2009) 1.01
Cholinotrophic molecular substrates of mild cognitive impairment in the elderly. Curr Alzheimer Res (2007) 1.00
A genotype resource for postmortem brain samples from the Autism Tissue Program. Autism Res (2011) 0.99
Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol (2012) 0.97
Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease. Dement Geriatr Cogn Disord (2006) 0.97
Galanin in Alzheimer disease. Mol Interv (2003) 0.97
Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction. Neurobiol Dis (2011) 0.97
Terminal Continuation (TC) RNA amplification enables expression profiling using minute RNA input obtained from mouse brain. Int J Mol Sci (2008) 0.96
Cystatin C rescues degenerating neurons in a cystatin B-knockout mouse model of progressive myoclonus epilepsy. Am J Pathol (2010) 0.94
Neuron-specific age-related decreases in dopamine receptor subtype mRNAs. J Comp Neurol (2003) 0.94
Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease. PLoS One (2012) 0.94
Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome. Neurobiol Dis (2013) 0.93
Galanin fiber hyperinnervation preserves neuroprotective gene expression in cholinergic basal forebrain neurons in Alzheimer's disease. J Alzheimers Dis (2009) 0.92
In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model. Neurobiol Aging (2008) 0.89
Galanin hyperinnervation upregulates choline acetyltransferase expression in cholinergic basal forebrain neurons in Alzheimer's disease. Neurodegener Dis (2008) 0.89
Plasma BDNF levels vary in relation to body weight in females. PLoS One (2012) 0.87
Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD). Brain Struct Funct (2014) 0.86
Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease. Arch Neurol (2009) 0.86
Glutamatergic transmission aberration: a major cause of behavioral deficits in a murine model of Down's syndrome. J Neurosci (2014) 0.86
Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease. Am J Pathol (2011) 0.85
Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease. Brain Pathol (2013) 0.84
The steroidogenic acute regulatory protein is expressed in steroidogenic cells of the day-old brain. Endocrinology (2004) 0.83
Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease. J Chem Neuroanat (2011) 0.83
Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice. J Comp Neurol (2014) 0.83
Expression profiling in the aging brain: a perspective. Ageing Res Rev (2005) 0.83
Neuroprotective role for galanin in Alzheimer's disease. EXS (2010) 0.83
Withdrawal of BDNF from hippocampal cultures leads to changes in genes involved in synaptic function. Dev Neurobiol (2014) 0.82
Systemic pathology in aged mouse models of Down's syndrome and Alzheimer's disease. Exp Mol Pathol (2008) 0.81
Expression profile analysis of vulnerable CA1 pyramidal neurons in young-Middle-Aged Ts65Dn mice. J Comp Neurol (2014) 0.80
Expression profiling and pharmacotherapeutic development in the central nervous system. Alzheimer Dis Assoc Disord (2004) 0.80
Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease. Curr Alzheimer Res (2016) 0.78
Hippocampal endosomal, lysosomal, and autophagic dysregulation in mild cognitive impairment: correlation with aβ and tau pathology. J Neuropathol Exp Neurol (2015) 0.78
Mitotic figures in the median eminence of the hypothalamus. Neurochem Res (2010) 0.77
Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome. Curr Alzheimer Res (2016) 0.77
Different inflammatory reactions to vitamin D3 among the lateral, third and fourth ventricular choroid plexuses of the rat. Exp Mol Pathol (2008) 0.76
Methods and compositions for amplification and detection of microRNAs (miRNAs) and noncoding RNAs (ncRNAs) using the signature sequence amplification method (SSAM). Recent Adv DNA Gene Seq (2014) 0.75
Vacuolar pathology in the median eminence of the hypothalamus after hyponatremia. J Neuropathol Exp Neurol (2011) 0.75
RNA amplification of bromodeoxyuridine labeled newborn neurons in the monkey hippocampus. J Neurosci Methods (2004) 0.75